Navigation Links
Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at American College of Gastroenterology Annual Scientific Meeting
Date:9/9/2008

SAN DIEGO, Sept. 9 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA) today announced that preclinical data will be presented on the Company's lead mitogen-activated ERK kinase (MEK) inhibitor, RDEA119, at the American College of Gastroenterology Annual Scientific Meeting at the Gaylord Palms Resort & Convention Center in Orlando.
The presentation details are as follows:

Date/Time: Tuesday, October 7, 2008 from 10:30 a.m. - 4:00 p.m. EDT

Abstract Title: "RDEA119, a Potent and Highly Selective MEK1 / 2 Inhibitor

is Beneficial in Dextran Sulfate Sodium (DSS)-Induced

Chronic Colitis in Mice"

Poster Number: P1050

Session Title: Inflammatory Bowel Disease

Location: Florida Exhibit Halls

About Ardea Biosciences, Inc.

Ardea Biosciences, Inc., of San Diego, California, is a biotechnology company focused on the discovery and development of small-molecule therapeutics for the treatment of HIV, gout, cancer and inflammatory diseases. We have five product candidates in clinical trials and others in preclinical development and discovery. Our most advanced product candidate is RDEA806, a non-nucleoside reverse transcriptase inhibitor (NNRTI), which has successfully completed a Phase 2a study for the treatment of patients with HIV. We have evaluated our second-generation NNRTI for the treatment of HIV, RDEA427, in a human micro-dose pharmacokinetic study and have selected it for clinical development. RDEA594, our lead product candidate for the treatment of gout, is being evaluated in a Phase 1 clinical trial and is believed to be an inhibitor of the URAT1 transporter in the kidney, which is responsible for regulation of uric acid levels. We
'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Ardea Biosciences Advances Lead Product Candidate for the Treatment of Gout, RDEA594, Into Phase 1 Clinical Trial
2. Ardea Biosciences Presents Phase 2a Antiviral Activity Data for Lead HIV Candidate, RDEA806 at XVII International AIDS Conference
3. Ardea Biosciences Reports Additional Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating Up to 1.9 Log Reduction in Plasma Viral Load with Once-Daily Dosing
4. Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program
5. Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis
6. Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594
7. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
8. Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors
9. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
10. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
11. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... MASON, Ohio , Dec. 23, 2014 /PRNewswire/ ... industry-leading treatment decision support to healthcare providers for ... that it has secured $30 million in equity ... Virginia C. Drosos , President and Chief ... increased clinical adoption and development of Assurex Health,s ...
(Date:12/24/2014)... Va. , Dec. 23, 2014  The ... diastolic blood pressure target for people with diabetes ... moderate or high doses of statins, in keeping ... management enacted by the American College of Cardiology ... are reflected in the most recent changes to ...
(Date:12/24/2014)... BARBARA, Calif. , Dec. 23, 2014 In ... Junior Doctors, Association of Sierra Leone , ... Sierra Leone for the treatment of local health ... While a new dedicated Ebola care center was constructed ... virus, the facility is not available for local Sierra Leonean ...
Breaking Medicine Technology:Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 4First Ebola Treatment Unit for Local Health Workers Arrives in Sierra Leone 2
... UPPSALA, Sweden, January 13 Beactica AB, the ... research,collaboration agreement with GE Healthcare (Chalfont St. Giles, ... tools, and Uppsala,University (Sweden). The collaboration ... GE Healthcare,s Biacore(TM) technology with,enzymology expertise from ...
... Life League,s historic Personhood Conference is featuring ... cell research and regenerative medicine.(Logo: ... CEO of AVM Biotechnology and President of ... over 17 years of experience in scientific ...
Cached Medicine Technology:Beactica Announces Fragment-Based Drug Discovery Research Collaboration With GE Healthcare and Uppsala University 2Stem Cell Pioneer to Speak to A.L.L. Personhood Conference 2
(Date:12/26/2014)... December 26, 2014 DW-InductionHeating.com (DaWei Induction ... designing, researching and developing, producing and marketing of a ... the business announces their new series of induction ... of the company, induction brazing refers to ... special filler material and heat. The manager says that ...
(Date:12/25/2014)... The microscopy market is estimated to grow at ... by 2019. Optical microscopy is the largest segment ... segment is expected to show the fastest growth ... nanotechnology, technological advancements, and increasing federal support to ... Full Copy of Report @ http://www.marketsandmarkets.com/Market-Reports/world-microscopy-399.html ...
(Date:12/25/2014)... The click strand woven bamboo ... durability. Today, the business announces a click strand ... Jan. 30, 2015. , Click strand woven bamboo ... is a well-known brand in the bamboo industry. ... a reliable bamboo flooring supplier. , “We are ...
(Date:12/25/2014)... Dallas, TX (PRWEB) December 26, 2014 ... Analysis to 2023” focuses on the current treatment landscape, ... colorectal cancer market. TS-1 is an anti-cancer drug which ... administered orally and is also used for treating gastric ... gimestat and otastat potassium. The drug was first approved ...
(Date:12/25/2014)... “Every three months the trends for ... evening dress will be one of the hottest styles in ... says. Today, the company releases 26 A-line sweetheart evening dresses, ... off. , “We are trying our best to help ... latest designs. Along with affordable prices, we provide discounted delivery ...
Breaking Medicine News(10 mins):Health News:Induction Brazing Equipment Series From DaWei Induction Heating Co., A Reliable Supplier Of Induction Heating Equipment 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3
... Surgery International Sends First American for Prostate Cancer ... American Surgical Team to TrinidadU.S. Risk Issues First ... Fla. and DALLAS, March 11 An uninsured ... last week for prostate cancer surgery -- to ...
... Lower Cost Female Condom Increases Access to Woman-Initiated ... Health Company (NYSE Alternext: FHC) today announced approval ... for the company,s FC2 Female Condom(R) (FC2), a ... sexually transmitted infections (STIs), HIV/AIDS, and unintended pregnancy. ...
... Claims Processing and PaymentBROOMFIELD, Colo., March 11 ... LVLT ) today announced that it has ... management services company, to provide that company,s primary network ... Level 3 will deliver direct Internet access and voice ...
... Credentials in Two States to Complex RehabDAYTON, Ohio, March ... specialist with 10 years of experience, has joined ... nation,s fastest growing accredited complex rehab companies. Witten is ... Ohio, for ASM ( www.alliance-seating.com ) and provides power ...
... alliance enables the direct sales of safe, high-quality ... March 11 It,s always been easy to ... recognize the value behind reusable Therma-Kool(R) Hot & ... Cold Packs. The therapy packs provide immediate relief ...
... More Exercise and Lose Weight NAPLES, Fla., March 11 ... and wellness resource, are helping all Hoosiers begin building ... nothing. Principals Stacy Bick and Rebecca Johnson are offering all ... www.youcanmakeitfit.com for only 99 cents a month if they ...
Cached Medicine News:Health News:Modern Health Care Economics is Driving Inventiveness in Delivery of Cancer Surgery and Management of Risk 2Health News:Modern Health Care Economics is Driving Inventiveness in Delivery of Cancer Surgery and Management of Risk 3Health News:Female Health Company Receives FDA Approval for FC2 Female Condom(R) 2Health News:Female Health Company Receives FDA Approval for FC2 Female Condom(R) 3Health News:Female Health Company Receives FDA Approval for FC2 Female Condom(R) 4Health News:Female Health Company Receives FDA Approval for FC2 Female Condom(R) 5Health News:Female Health Company Receives FDA Approval for FC2 Female Condom(R) 6Health News:Level 3 Provides Primary Connectivity for MDI Holdings 2Health News:Level 3 Provides Primary Connectivity for MDI Holdings 3Health News:Nurse & Veteran Rehab Specialist, Terri Witten, Joins Fast-Growing Alliance Seating & Mobility in Ohio 2Health News:Nortech Labs, Inc. and MEDNET(TM) Make for a Notable, Natural Partnership 2Health News:Nortech Labs, Inc. and MEDNET(TM) Make for a Notable, Natural Partnership 3Health News:Make It Fit America Inc. Offers Virtually Free Fitness Service on 'Make Indiana Fit Day' 2Health News:Make It Fit America Inc. Offers Virtually Free Fitness Service on 'Make Indiana Fit Day' 3
... a scientifically advanced multinutrient that ... and full body health. It ... including a diverse array of ... lycopene and OptiBerry and important ...
... Ocuvite® Extra vitamin and mineral supplements ... original formula plus more. Ocuvite ... and higher levels of vitamins C ... also contains other antioxidants and minerals ...
HydroEye is an exclusive formulation designed to provide dry eye relief and support the body's natural tear formation. Like all ScienceBased Health formulations, it is produced in softgel form for ma...
Expert QC data management solution...
Medicine Products: